Advertisement

Preliminary results of the Cardiac Arrest Study Hamburg (CASH)

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Sodium channel Mockers and class III antiarrhythmic compounds, as well as β blockers, have been used in preventing recurrences of sudden cardiac death. In recent years, implantable cardioverter-defibrillators (ICDs) have been used increasingly, but no data from randomized trials comparing antiarrhythmic drug and ICD therapy have been reported in this setting. In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, randomized trial, was initiated to compare metoprolol, amiodarone, propafenone, and ICD implantation in patients surviving sudden cardiac death due to documented ventricular tachycardia and/or ventricular fibrillation. The details of the study design and preliminary results are presented herein. The primary endpoint of the study is total mortality. The data reviewed in March 1992, representing a mean follow-up period of 11 months, indicated no significant differences among patients randomized to metoprolol, amiodarone, and ICDs. However, there was a significantly higher total mortality and cardiac arrest recurrence in patients randomized to propafenone compared with those randomized to the ICD treatment limb. The study continues with the deletion of the propafenone treatment limb.
      To read this article in full you will need to make a payment

      References

        • Gillum RF
        Sudden coronary death in the United States, 1980–1985.
        Circulation. 1989; 79: 756-765
        • Kannel WB
        • Schatzkin A
        Sudden death: lessons from subsets in population studies.
        J Am Coll Cardiol. 1985; 5 (suppl): 141B-149B
        • Rapaport E
        Sudden cardiac death.
        Am J Cardiol. 1988; 62: 31-61
        • Wilber DJ
        • Garan H
        • Finkelstein D
        • Kelly E
        • Newell J
        • Mc Govern B
        • Ruskin JN
        Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome.
        N Engl Med. 1988; 318: 19-24
        • Freedman R
        • Swerdlow CD
        • Soderholm-Diffatte V
        • Mason JW
        Prognostic significance of arrhythmia inducibility or non-inducibility at initial electrophysiologic study in survivors of cardiac arrest.
        Am J Cardiol. 1988; 61: 578-582
        • Kempf FC
        • Josephson ME
        Cardiac arrest recorded on ambulatory electrocardiograms.
        Am J Cardiol. 1984; 53: 1577-1582
        • Fozzard HA
        Electromechanical dissociation and its possible role in sudden cardiac death.
        Am J Cardiol. 1985; 5: 31b-34b
        • Swerdlow CD
        • Winkle RA
        • Mason JW
        Determinants of survival in patients with ventricular tachyarrhythmias.
        N Engl J Med. 1983; 308: 1436-1442
        • Ruskin JN
        • DiMarco JP
        • Garan H
        Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy.
        N Engl J Med. 1980; 303: 607-612
        • Roy D
        • Waxman HL
        • Kienzle MG
        • Buxton AE
        • Marchlinski FE
        • Josephson ME
        Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing.
        Am J Cardiol. 1983; 52: 969-974
        • Morady F
        • Scheinman MM
        • Hess DS
        • Sung RJ
        • Shen E
        • Shapiro W
        Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest.
        Am J Cardiol. 1983; 51: 85-89
        • Poole EP
        • Mathisen TL
        • Kudenchuk PJ
        • McAnulty JH
        • Swerdlow CD
        • Bardy GH
        • Greene HL
        Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
        J Am Coll Cardiol. 1990; 16: 657-665
        • Winkle RA
        • Mead RH
        • Ruder MA
        • Gaudiani VA
        • Smith NA
        • Buch WS
        • Schmidt P
        • Shipman T
        Long-term outcome with the automatic implantable cardioverter-defibrillator.
        J Am Coll Cardiol. 1989; 13: 1353-1361
        • Mason JW
        • On behalf of E SVEM Investigators
        A randomized comparison of electrophysiologic study to electrocardiographic monitoring for prediction of antiarrhythmic drug efficacy in patients with ventricular tachyarrhythmias.
        N Engl J Med. 1993; 329: 445-451
        • Mason JW
        • On behalf of ESVEM Investigators
        A comparison of seven anti-arrhythmic drugs in patients with ventricular tachyarrhythmias.
        N Engl J Med. 1993; 329: 452-458
        • The Cardiac Arrhythmia Supression Trial (CAST) Investigators
        Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia supression after myocardial infarction.
        N Engl J Med. 1989; 321: 406-412
        • The Cardiac Arrhythmia Supression Trial II Investigators
        Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction.
        N Engl J Med. 1992; 327: 227-233